Cost-Effectiveness Assessment of Orphan Drugs Steven SimoensEline PicavetThomas Morel Editorial 18 December 2012 Pages: 1 - 3
Pipeline™ Embolization Device for the Treatment of Complex Intracranial Aneurysms Kathleen WithersGrace Carolan-ReesMegan Dale Review Article Open access 23 January 2013 Pages: 5 - 13
The Economic Evaluation of Medical Devices Andreas KirisitsW. Ken Redekop Review Article 04 January 2013 Pages: 15 - 26
A Systematic Review of Economic Evaluations in Second and Later Lines of Therapy for the Treatment of Non-Small Cell Lung Cancer Anne JäkelMelanie PlestedAdam Johns Systematic Review 26 October 2012 Pages: 27 - 43
Lessons from Game Theory about Healthcare System Price Inflation Mark D. AgeeZane Gates Original Research Article 11 December 2012 Pages: 45 - 51
Assessing the Cost Utility of Response-Guided Therapy in Patients with Chronic Hepatitis C Genotype 1 in the UK Using the MONARCH Model Phil McEwanRay KimYong Yuan Original Research Article 14 November 2012 Pages: 53 - 63
Cost-Effectiveness Analysis of Boceprevir for the Treatment of Chronic Hepatitis C Virus Genotype 1 Infection in Portugal Elamin H. ElbashaJagpreet ChhatwalPedro A. Laires Original Research Article 26 January 2013 Pages: 65 - 78
A New Reimbursement System for Innovative Pharmaceuticals Combining Value-Based and Free Market Pricing Brian GodmanLars L. Gustafsson Correspondence 16 January 2013 Pages: 79 - 82
Authors’ Reply to Godman and Gustafsson: “A New Reimbursement System for Innovative Pharmaceuticals Combining Value-Based and Free Market Pricing” Ulf PerssonJohanna SvenssonBillie Pettersson Correspondence 29 January 2013 Pages: 83 - 84